Integrated Biopharma Inc
Integrated BioPharma, Inc., together with its subsidiaries, engages in the manufacturing, distributing, marketing and sale of vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. The company operates through two segments, Contract Manufacturing and Other Business Lines. The Contract Manufacturing segment manufactures vitamins and nutritional supple… Read more
Market Cap & Net Worth: Integrated Biopharma Inc (INBP)
Integrated Biopharma Inc (OTCQX:INBP) has a market capitalization of $9.01 Million ($9.01 Million) as of March 18, 2026. Listed on the OTCQX stock exchange, this USA-based company holds position #33206 globally and #10854 in its home market, demonstrating a -14.71% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Integrated Biopharma Inc's stock price $0.29 by its total outstanding shares 31059610 (31.06 Million).
Integrated Biopharma Inc Market Cap History: 2015 to 2025
Integrated Biopharma Inc's market capitalization history from 2015 to 2025. Data shows growth from $3.11 Million to $9.01 Million (13.85% CAGR).
Integrated Biopharma Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Integrated Biopharma Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.17x
Integrated Biopharma Inc's market cap is 0.17 times its annual revenue
0.14x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
11.15x
Integrated Biopharma Inc's market cap is 11.15 times its annual earnings
5.50x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $7.04 Million | $42.21 Million | $958.00K | 0.17x | 7.34x |
| 2017 | $5.59 Million | $46.95 Million | $2.35 Million | 0.12x | 2.38x |
| 2018 | $4.58 Million | $43.71 Million | $679.00K | 0.10x | 6.75x |
| 2019 | $7.61 Million | $49.98 Million | $1.69 Million | 0.15x | 4.51x |
| 2020 | $22.92 Million | $52.77 Million | $4.11 Million | 0.43x | 5.58x |
| 2021 | $32.30 Million | $63.56 Million | $8.01 Million | 0.51x | 4.03x |
| 2022 | $10.87 Million | $56.25 Million | $3.84 Million | 0.19x | 2.83x |
| 2023 | $7.76 Million | $50.67 Million | -$34.00K | 0.15x | N/A |
| 2024 | $9.94 Million | $50.32 Million | $112.00K | 0.20x | 88.74x |
| 2025 | $9.01 Million | $54.35 Million | $808.00K | 0.17x | 11.15x |
Competitor Companies of INBP by Market Capitalization
Companies near Integrated Biopharma Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Integrated Biopharma Inc by market ranking:
- Nestle SA (PINK:NSRGF): Ranked #55 globally with a market cap of $258.19 Billion USD.
- Nestlé S.A. (SW:NESN): Ranked #68 globally with a market cap of $226.90 Billion USD ( CHF207.77 Billion CHF).
- Danone S.A (OTCQX:GPDNF): Ranked #437 globally with a market cap of $49.73 Billion USD.
- Danone SA (PA:BN): Ranked #458 globally with a market cap of $47.46 Billion USD ( €46.23 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #55 | Nestle SA | PINK:NSRGF | $258.19 Billion | $100.43 |
| #68 | Nestlé S.A. | SW:NESN | $226.90 Billion | CHF80.84 |
| #437 | Danone S.A | OTCQX:GPDNF | $49.73 Billion | $78.67 |
| #458 | Danone SA | PA:BN | $47.46 Billion | €73.12 |
Integrated Biopharma Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Integrated Biopharma Inc's market cap moved from $3.11 Million to $ 9.01 Million, with a yearly change of 13.85%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $9.01 Million | -9.38% |
| 2024 | $9.94 Million | +28.00% |
| 2023 | $7.76 Million | -28.57% |
| 2022 | $10.87 Million | -66.35% |
| 2021 | $32.30 Million | +40.92% |
| 2020 | $22.92 Million | +201.22% |
| 2019 | $7.61 Million | +66.10% |
| 2018 | $4.58 Million | -18.01% |
| 2017 | $5.59 Million | -20.57% |
| 2016 | $7.04 Million | +126.50% |
| 2015 | $3.11 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Integrated Biopharma Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $9.01 Million USD |
| MoneyControl | $9.01 Million USD |
| MarketWatch | $9.01 Million USD |
| marketcap.company | $9.01 Million USD |
| Reuters | $9.01 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.